FlexAbility SE Ablation Catheter

DEVICE2 trials

Sponsors

Abbott Medical Devices

Conditions

Ventricular Tachycardia

Unknown Phase

FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

CompletedNCT03490201

Abbott Medical DevicesVentricular Tachycardia

Start: 2018-06-01End: 2024-04-11Updated: 2025-01-08

Abbott Ventricular Tachycardia PAS

Active, not recruitingNCT05839873

Abbott Medical DevicesVentricular Tachycardia

Start: 2023-07-24End: 2026-11-30Updated: 2025-10-17

Related Papers

Cryocure-VT: the safety and effectiveness of ultra-low-temperature cryoablation of monomorphic ventricular tachycardia in patients with ischaemic and non-ischaemic cardiomyopathies

EP Europace2024-03-3014 citations